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Aims Under hypoxic conditions, nitrite (NO-2) can be reduced to nitric oxide (NO) eliciting vasorelaxation. However, ni-
trite also exerts vasorelaxant effects of potential therapeutic relevance under normal physiological conditions via
undetermined mechanisms. We, therefore, sought to investigate the mechanism(s) by which nitrite regulates the
vascular system in normoxia and, specifically, whether the biological effects are a result of NO generation (as in
hypoxia) or mediated via alternative mechanisms involving classical downstream targets of NO [e.g. effects on pro-
tein kinase G1a (PKG1a)].
....................................................................................................................................................................................................
Methods
and results
Ex vivo myography revealed that, unlike in thoracic aorta (conduit vessels), the vasorelaxant effects of nitrite in mes-
enteric resistance vessels from wild-type (WT) mice were NO-independent. Oxidants such as H2O2 promote disul-
fide formation of PKG1a, resulting in NO- cyclic guanosine monophosphate (cGMP) independent kinase activation.
To explore whether the microvascular effects of nitrite were associated with PKG1a oxidation, we used a
Cys42Ser PKG1a knock-in (C42S PKG1a KI; ‘redox-dead’) mouse that cannot transduce oxidant signals. Resistance
vessels from these C42S PKG1a KI mice were markedly less responsive to nitrite-induced vasodilation.
Intraperitoneal (i.p.) bolus application of nitrite in conscious WT mice induced a rapid yet transient increase in
plasma nitrite and cGMP concentrations followed by prolonged hypotensive effects, as assessed using in vivo teleme-
try. In the C42S PKG1a KI mice, the blood pressure lowering effects of nitrite were lower compared to WT.
Increased H2O2 concentrations were detected in WT resistance vessel tissue challenged with nitrite. Consistent
with this, increased cysteine and glutathione persulfide levels were detected in these vessels by mass spectrometry,
matching the temporal profile of nitrite’s effects on H2O2 and blood pressure.
....................................................................................................................................................................................................
Conclusion Under physiological conditions, nitrite induces a delayed and long-lasting blood pressure lowering effect, which is
NO-independent and occurs via a new redox mechanism involving H2O2, persulfides, and PKG1a oxidation/activa-
tion. Targeting this novel pathway may provide new prospects for anti-hypertensive therapy.
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Graphical Abstract
1. Introduction
Despite current pharmacotherapies and interventional procedures, arte-
rial hypertension remains a global health burden and a major risk factor
for cardiovascular diseases, dementia, renal failure, and premature
death.1 Inorganic nitrite (NO2
-) elicits vasorelaxation and lowers blood
pressure when infused. Due to the potential beneficial effects and the
possible therapeutic utility of NO2
- in treating hypertension, it becomes
essential to understand the mechanism(s) and efficacy by which NO2
-
elicits vasorelaxation under normoxia.2
Augmentation of plasma nitrite by oral administration of inorganic ni-
trate (converted to nitrite by oral/gut bacteria following enterosalivary
circulation) has been shown to effectively reduce blood pressure in vari-
ous animal models and in healthy human subjects.2–5 It is now clear that
at least some of the pharmacological actions of nitrite are mediated via
its reduction to nitric oxide (NO) and increased NO/cyclic guanosine
monophosphate (cGMP)-signalling under conditions of low pH and oxy-
gen tension.6,7 Whilst this nitrite-NO pathway offers a conceptually at-
tractive explanation for the blood pressure lowering effect during
hypoxia, nitrite also has vasorelaxant and blood pressure lowering
effects under normoxic conditions. However, the mechanism(s) respon-
sible for these effects remain incompletely understood. We have shown
that under normoxic conditions, the rate of conversion of nitrite to NO
is extremely slow,8 suggesting that these effects may be NO-
independent. Using single intraperitoneal (i.p.) injections of nitrite in rats,
we previously demonstrated that nitrite was rapidly absorbed and me-
tabolized to nitrate and nitroso/nitrosyl products in all but two tissues
studied (brain and aorta)9; this was accompanied by cardioprotection
and a sustained (48 h) increase in ascorbate oxidation in the heart,
reflecting persistent changes in tissue redox status.10
The mechanism responsible for the vasoactivity of NO (which can be
generated from nitrite under hypoxic conditions) is well established and
involves activation of the enzyme soluble guanylyl cylase (sGC), resulting
in an increase in the generation of the second messenger cGMP with
consecutive activation of the cGMP-binding kinase protein kinase G1a
(PKG1a), which further transduces the signal associated with vaso-
relaxation.11 We have previously shown that PKG1a itself is subject to
redox regulation such that the presence of oxidants can result in inter-
protein disulfide formation, which translates into an increase in enzyme
activity without changes in cGMP.12,13 Thus, species such as hydrogen
peroxide (H2O2) that are capable of causing thiol to disulfide oxidation
can elicit smooth muscle relaxation, and therefore, lead to vasodilation
via oxidative activation of PKG1a in an NO-cGMP-independent fashion.
Stubbert et al.14 also reported that polysulfur species derived from hy-
drogen sulfide (H2S) oxidation are capable of activating PKG1a via oxida-
tion. The generation of polysulfur species and/or other sulfur oxidants
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(e.g. H2O2) therefore represents a NO-independent mechanism of
PKG1a activation, which could also translate into vasorelaxation. Thus, if
nitrite-mediated vasorelaxation under normoxic conditions was found
to be NO-independent, it is possible that nitrite is capable of eliciting vas-
orelaxation via oxidative activation of PKG1a.
Recently, reactive sulfur species known as persulfides (RSSH) and pol-
ysulfides (RSnSR, RSSnH, n> 1) originating from sulfur-containing amino
acid metabolism were detected in mammalian tissues and fluids.15
Specifically, cysteine persulfide (CysSSH), glutathione persulfide (GSSH)
and related species may function as potent antioxidants, cytoprotectants,
and redox signalling intermediates,16 and CysSSH appears to be involved
in the regulation of mitochondrial biogenesis and bioenergetics.17
However, the physiological relevance and function of these species is in-
completely understood, and whether nitrite has the ability to generate
these polysulfur species is unknown.
The significance of nitrite as a redox regulator is not yet widely recog-
nized, and evidence for the possible involvement of these pathways in its
blood pressure lowering effects under physiological conditions is lacking.
In the present study, we, therefore, sought to explore whether nitrite
has the ability to mediate redox signalling and reduce vascular tone un-
der normoxic conditions. We hypothesized that nitrite induces vasodila-
tion and lowers blood pressure by generating endogenous thiol
oxidants, such as H2O2 and persulfides, to eventually induce oxidation of
PKG1a. We integrated in vitro and in vivo approaches to investigate the
redox properties of nitrite. Our studies were further supported by the
use of ‘redox-dead’ Cys42ser PKG1a knock-in (C42S PKG1a KI) mice,
which are unable to transduce oxidant signals because the cysteinyl thiol
has been replaced by a hydroxyl group, and therefore this mutation pre-
vents the oxidative activation of PKG1a. We demonstrate that a single
bolus application of nitrite induces long-lasting blood pressure lowering
effects by generating H2O2 and persulfide species in the resistance ves-
sels to activate PKG1a in an NO-independent manner.
2. Methods
All experiments were performed under a UK Home Office Licence and
conducted according to the Animals Scientific Procedures Act 1986
(UK) and directive 2010/63/EU of the European Parliament guidelines on
the protection of animals used for scientific purposes. All experiments
were approved by the Institutional Animal Welfare and Ethical Review
Body. Male wild-type (PKG1a-WT) or PKG1a Cys42Ser knock-in
(C42S PKG1a KI) mice were bred and maintained inhouse.13 Male
C57BL/6 mice (background for the PKG1a Cys42Ser mice) were pur-
chased from Charles River Laboratories (Massachusetts, USA), and all
mice were age- and body weight-matched.
2.1 Tissue harvest and blood sampling
C57BL/6 mice were administered a single i.p. injection of sodium nitrite
(Sigma-Aldrich, Missouri, USA) dissolved in sterile saline (Baxter
Healthcare, Deerfield, IL, USA; 0.9%) at various doses [0 (vehicle con-
trol), 0.1, 1.0, and 10 mg/kg body weight9,10]. Following nitrite treatment
1 or 24 h previously, mice were terminally anaesthetized [i.p. injection of
pentobarbital sodium (300 mg/kg) mixed 50:50 with anticoagulant hepa-
rin (150 units)] and biological specimens were harvested. Blood was col-
lected and supplemented with N-ethylmaleimide (NEM) and EDTA from
a 10 stock in phosphate buffered saline to yield final concentrations of
10 mM NEM/1 mM EDTA and centrifuged for 10 min at 1000 g to sepa-
rate plasma from blood cells. Plasma was then aliquoted, snap frozen in
liquid nitrogen, and stored at -80C until further analysis for nitrite/ni-
trate and cGMP. Thoracic aorta (conduit) and mesenteric resistance ves-
sels were immediately isolated, dissected in ice-cold Krebs Henseleit
buffer (KHB),12,18 divided into aliquots, snap frozen, and stored at -80C
until analysis for persulfides and H2O2. The liver was isolated in situ, per-
fused free of blood, snap frozen, and stored at -80C for in vitro investiga-
tions of nitrite’s effects on catalase activity. Mice were euthanized by
cervical dislocation.
2.2 Functional studies on isolated blood
vessels
Conduit vessel rings were isolated from the thoracic aorta, and second-
order mesenteric arteries (resistance vessels) from PKG1a WT and
C42S PKG1a KI mice. Blood vessels were mounted in a tension myo-
graph (Danish Myo Technology, Hinnerup, Denmark) containing KHB
(37C, pH 7.4) and gassed with 95% O2/5% CO2. After equilibration,
vascular reactivity was normalized as previously described.12,18
Submaximal vasocontraction in both vessel types was induced by addi-
tion of phenylephrine (PE; Sigma-Aldrich, Missouri, USA) or U46619
(Cambridge Biosciences, Cambridge, UK), respectively, to the organ
bath. Relaxation-response curves to sodium nitrite were constructed in
the absence or presence of the selective soluble guanylate cyclase inhibi-
tor, 1H-[1,2,4] oxadiazolo[4,3,-a]quinoxalin-1-one (ODQ; Sigma-
Aldrich, Missouri, USA; 10mM19) or the NO scavenger, 2-4-carboxy-
phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (CPTIO; Enzo Life
Sciences, Exeter, UK; 1 mM19), and results expressed as a percentage of
stable precontractile tone achieved.
2.3 Telemetric blood pressure monitoring
in vivo
Mean arterial pressure (MAP) in conscious, freely moving PKG1a WT
and C42S PKG1a KI mice was assessed using telemetry, as previously
described.13 Briefly, mice were anaesthetized with 2% isoflurane in 0.5 l
of oxygen per minute, and a TA11PA-C10 probe catheter (Data Science
International, Minnesota, USA) was implanted in the aortic arch via the
left aortic carotid artery. Pre- and post-operative analgesia (buprenor-
phine, subcutaneous injection of 0.1 mg/kg of body weight; Abbot
Laboratories, Illinois, USA) was also provided, and the wellbeing of mice
monitored daily. After 1 week recovery, mice were placed on the tele-
metric receivers, and MAP was recorded every 5 min. Blood pressures
were measured throughout the day for 72 h before the start of the ex-
periment. Mice then received a single i.p. injection of 0.1 mg/kg sodium
nitrite dissolved in sterile saline and their blood pressure was monitored
for further 24 h, followed by the administration of a successive 10-fold
higher dose of nitrite at the same time on the subsequent 2 days while
blood pressure monitoring continued.
2.4 Mass spectrometric analyses of tissue
persulfide concentrations
High performance liquid chromatography-electrospray ionization tan-
dem mass spectrometry (LC-ESI-MS/MS) analysis of tissue homogenates
following HPE-IAM derivatization was used to determine CysSSH,
GSSH, and inorganic persulfide (HSSH; disulfane), as previously
described.17 Briefly, mesenteric and aortic tissues were homogenized
with ice-cold 100% methanol solution containing 5 mM HPE-IAM and
then incubated at 37C for 30 min. The homogenates were then centri-
fuged at 15 000 g for 10 min to remove the protein pellet. After centrifu-
gation, the aliquots of the supernatants were diluted with 0.1% formic
Nitrite-induced hypotension occurs via H2O2 and cysteine persulfide formation and PKG1a oxidation 53
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acid containing known amounts of isotope-labelled internal standards.
The samples were then analysed for CysSSH, GSSH, and HSSH by LC-
ESI-MS/MS.
To assess the potential of H2O2 to induce the formation of persulfides
from thiols and sulfide under various reaction conditions, L-cysteine
(100mM) or L-glutathione (100mM), and sodium hydrosulfide (NaHS;
100mM) was mixed with H2O2 (100mM) in Tris/HCl (pH 7.5 or pH 9)
or acetate buffer (pH 5.6) containing 2 mM HPE-IAM. The reaction solu-
tions were incubated at room temperature for 10, 30, 60, 90, or 120 min
and subsequently analysed for cysteine (CysSH), CysSSH, HSH, HSSH,
GSH, and GSSH.
2.5 Plasma nitrite/nitrate and cyclic GMP
determination
Nitrite and nitrate were quantified in plasma as previously described.10,20
Plasma cGMP was determined using a commercially available assay kit
(KGE003 R&D systems, Minneapolis, UK).
2.6 Tissue hydrogen peroxide
Hydrogen peroxide concentrations were measured in tissue (mesen-
teric and thoracic aorta) using a commercially available assay kit
(ab102500 Abcam, Cambridge, UK).
2.7 Tissue catalase activity
Tissue catalase activity was determined by monitoring the rate of H2O2
disappearance in the absence and presence of different nitrite concentra-
tions (for order of reagent addition see Supplementary material online,
Figure S1D). H2O2 concentrations were quantified using the horseradish
peroxidase-mediated oxidation of phenol red and compared to a calibra-
tion curve with absorbance readings taken at 610 nm.21 For these experi-
ments, frozen mouse liver aliquots were homogenized at 1:4 ratio (w/v)
in EDTA-containing phosphate buffer pH 7.4 using a glass–glass Potter-
Elvehjem tissue homogenizer immersed in an ice/water bath. The ho-
mogenization buffer was supplemented with NEM (10 mM, final concen-
trations) to minimize potential thiol-mediated metabolic conversion of
nitrite to nitroso species. The homogenate was centrifuged (13 000 g,
15 min, 4C), and kept on ice in the dark for up to 1 h for measurements
of catalase activity, in the absence and presence of nitrite.
3. Results
3.1 Nitrite regulates mesenteric resistance
vasorelaxation NO-independently during
normoxia
To determine whether in the presence of oxygen nitrite mediates vaso-
relaxation in an NO-independent or independent fashion, we first con-
structed cumulative concentration-response curves to nitrite in isolated
pre-constricted mesenteric resistance vessels mounted in wire-
myographs (Figure 1). Pre-incubation of resistance vessels from the wild-
type (WT) mice with either the NO-scavenger, carboxy-PTIO or the
sGC inhibitor, ODQ failed to abrogate vasorelaxation in the resistance
vessels from WT mice (Figure 2A and B), indicating that the effects of ni-
trite in this tissue were largely NO/sGC independent. In contrast, when
wire-myography was performed in conduit vessels (thoracic aorta)
nitrite’s vasorelaxant effects were clearly NO/sGC-dependent (Figure 2C
and D).
In light of the above, we hypothesized that nitrite-mediated vasorelax-
ation may perhaps occur via PKG1a oxidation, independent of the classi-
cal NO-cGMP pathway. To explore this possibility, we used a ‘redox-
dead’ genetic variant of PKG1a whereby the important regulatory SH
moiety has been mutated to a redox inactive OH group (by replacing a
Figure 1 Schematic experimental design to assess nitrite-induced vasodilatory and blood pressure lowering effects as well as biochemical changes during
normoxia.
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single cysteine, Cys42, against serine).13 Using this C42S PKG1a knock-
in (KI) mouse model and WT littermates as a comparator, we next in-
vestigated the molecular target involved in nitrite-mediated vasorelaxa-
tion (Figure 1). Nitrite-relaxed WT vessels in a concentration-dependent
fashion, but did not relax resistance vessels from C42S PGK1a KI mice
(Figure 2E); whereas in the conduit vessels, nitrite was not mediated
through PKG1a oxidation (Figure 2F).
To translate our findings into the in vivo setting, we administered i.p.
injections of sodium nitrite (0.1, 1, and 10 mg/kg) in WT mice on three
consecutive days following 72 h continuous telemetric arterial blood
pressure monitoring. Compared to the hourly averages for the 3 days
baseline blood pressure measurements shown, reductions in blood pres-
sure were not apparent until 4–5 h after the nitrite application (Figures 1
and 3A; WT-black trace), but blood pressure remained reduced for al-
most 24 h, especially during the nocturnal period when the animals were
most active (Figure 3B, WT-black bars). Unexpectedly, the magnitude of
blood pressure lowering by the three doses was similar.
We next assessed the in vivo blood pressure lowering effects of nitrite
in redox-dead C42S PKG1a KI using the same treatment regime as in
their PKG-WT littermates (see above). Of note, the C42S PKG1a KI
had modestly, but consistently higher mean blood pressure than the
WT.13 In contrast to the long-lasting hypotensive effects seen with nitrite
in WT mice, C42S PKG1a KI animals did not show a blood pressure
lowering effect. Figure 3A compares the 24 h MAP data in both genotypes
following i.p. administration of sodium nitrite (0.1, 1, and 10 mg/kg).
Figure 3B is further simplified to illustrate the delta difference between
baseline and response to nitrite treatment at night. There was a signifi-
cant difference between the two genotypes (*P< 0.05 determined by re-
peated measures two-way ANOVA). These results are consistent with
the notion that the ability of nitrite to elicit persistent hypotension
depends on its capacity to oxidatively activate PKG1a.
In a separate group of C57BL/6 mice, the same nitrite injection regime
was used and blood samples were taken 1 and 24 h post-treatment for
measurement of plasma nitrite, nitrate, and cGMP (Figures 1 and 3C–E).
Figure 2 Mesenteric and thoracic blood vessels from PKG-1a WT and C42S PKG1a KI were mounted in myograph and sub-maximally constricted with
U46619 and phenylephrine, respectively. Pre-incubation of isolated mesenteric resistance vessels from WT to (A) NO scavenger, carboxy-PTIO (CPTIO;
1 mM; n= 15) or (B) soluble guanylate cyclase inhibitor (sGC), ODQ (10mM; n= 14) did not attenuate the vasodilatory response to nitrite in WT mice.
Concentration response curves to nitrite in isolated thoracic aorta. Vasorelaxant effects of nitrite was (C) NO-dependent (n= 7) and (D) sGC-dependent in
WT mice (n= 11). Concentration response curves to sodium nitrite in (E) isolated mesenteric resistance vessels from both genotypes (n= 19). Nitrite was
significantly less effective as a vasodilator in C42S PKG1a KI mice, but not in the (F) thoracic aorta (conduit vessels; n= 13–14). Data are expressed as
mean ± S.E.M. ***P<_ 0.001 as determined by two-way ANOVA with Bonferroni’s test (A–F).
Nitrite-induced hypotension occurs via H2O2 and cysteine persulfide formation and PKG1a oxidation 55
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Plasma nitrite and nitrate acutely increased in a dose-dependent manner,
and this was statistically significant at the highest dose (i.e. 3–4 h before a
BP-lowering effect was observed), as determined by two-way ANOVA.
Following Tukey’s multiple comparisons test 10 mg/kg sodium nitrite,
plasma nitrite was significantly higher at 1 h when compared with control
vehicle, 0.1 and 1 mg/kg; *P< 0.05). However 24 h later plasma nitrite, ni-
trate, and cGMP were similar to baseline concentrations even at the
highest dose (despite persistent BP reduction persisting for almost 24 h);
these changes were consistent with our previous results in rats subjected
to i.p. nitrite administration, demonstrating that plasma nitrite levels rap-
idly increased, but returned close to baseline values in1 h.9,10
3.2 Nitrite increases hydrogen peroxide
levels
We next focused on the mechanism of nitrite-mediated vasorelaxation
of resistance arteries and blood pressure lowering. Nitrite has the po-
tential to inhibit catalase,22,23 which may conceivably lead to an increased
oxidative tone by reducing the breakdown of endogenously produced
H2O2. This action was confirmed in complementary studies in which ni-
trite was found to be capable of inhibiting catalase activity in hepatic tis-
sue in vitro (Supplementary material online, Figure S1). In order to
determine whether this can also occur in vascular tissue, we measured
ex vivo H2O2 concentrations in blood vessels harvested 1 and 24 h after
nitrite pre-treatment in vivo (Figure 1). As depicted in Figure 4A, nitrite
caused a significant and similar increase in steady-state concentrations of
H2O2 in mesenteric resistance vessels with both 1 and 10 mg/kg nitrite
at 1 h, which persisted at 24 h. Whilst nitrite also triggered an increase of
this oxidant in the aorta at 1 h, H2O2 concentrations had returned to
normal at 24 h (Figure 4B), revealing kinetic differences in H2O2 handling
between these two types of vessels.
3.3 Nitrite increases CysSSHs and GSSH in
resistance vessels during normoxia
The results presented thus far indicate that nitrite produces H2O2 and
induces vasorelaxation by oxidation of PKG1a. We next examined
whether there was a possible intermediate that links these effects. We
surmised that nitrite may have the ability to oxidatively activate PKG1a
via the generation of polysulfur species. To establish whether nitrite gen-
erates polysulfur species in vivo, mesenteric resistance and thoracic aorta
blood vessels were harvested from WT mice (C57BL/6) treated with
bolus i.p. administration of vehicle control or sodium nitrite (0.1, 1, and
10 mg/kg) for 1 or 24 h. The levels of persulfides (CysSSH, GSSH,
and HSSH) were analysed by LC-ESI-MS/MS following derivation with
b-(4-hydroxyphenyl)ethyliodoacetamide (HPE-IAM). We observed
Figure 3 C42S PKG1a KI mice are resistant to nitrite-induced blood pressure lowering compared with age-matched WT littermates, as measured by
in vivo telemetry (n= 6 WT and 7 KI). (A) Comparison of the 24 h averaged changes in MAP in both genotypes following bolus administration of sodium ni-
trite (0.1, 1, and 10 mg/kg). WT mice, but not for KI mice, there was a significant difference in blood pressure lowering effect with each nitrite dose when
compared to baseline. (B) Delta indicates the difference between baseline and response to treatment at night. In separate group of WT mice (C57BL/6), fol-
lowing bolus i.p. administration with sodium nitrite (vehicle control, 0.1, 1, and 10 mg/kg) for 1 or 24 h treatment, plasma samples were taken (C) nitrite, (D)
nitrate, and (E) cGMP (n= 4–7 mice/group). Data are represented as mean ± S.E.M. *P<_ 0.05 when WT mice compared to each nitrite dose with baseline
(repeated measures one-way ANOVA, A). *P<_ 0.05 between two different genotypes was determined by repeated measures two-way ANOVA (B).
Significant time and concentration interaction for plasma nitrite and nitrate, as determined by two-way ANOVA. Following Tukey’s multiple comparisons
test 10 mg/kg sodium nitrite was significant when compared to control vehicle, 0.1 and 1 mg/kg (*P<_ 0.05; C and D). There was no significant difference be-
tween nitrite concentration for cGMP levels at either time (P> 0.05; two-way ANOVA followed by Tukey’s multiple comparisons test; E).
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.dose-dependent increases in CysSSH and GSSH in the resistance vessels
(Figure 5A and B) with progressively lower concentrations of HSSH
(Figure 5C). In contrast, we observed no changes in CysSSH, GSSH, or
HSSH formation in the conduit vessels (Figure 5D–F, respectively). In fur-
ther in vitro studies, we sought to confirm experimentally that H2O2 is ca-
pable of inducing polysulfidation when inorganic sulfide and cysteine are
present. This was indeed found to be the case under a variety of pH and
H2O2 conditions (Figures 6A–C), and similar results were observed with
glutathione/sulfide/H2O2 (Figure 6D).
4. Discussion
We have previously shown that the conversion of nitrite to NO is inhib-
ited by oxygen,8 and the mechanism(s) through which it exerts its phar-
macological effects under normoxia remain(s) poorly understood.
Whilst blood pressure lowering effects of nitrite have been shown in var-
ious animal models and clinical studies, to the best of our knowledge, the
impact of long-lasting effects of single bolus application of nitrite during
physiological conditions has not been investigated. In the present study,
we demonstrate that a single bolus application of nitrite elicits a long-
lasting blood pressure lowering effect that is unrelated to the generation
of NO. We furthermore show that a marked temporal dissociation
exists between plasma nitrite and cGMP concentrations, and the blood
pressure lowering effects of i.p. injections of nitrite, with the hypotensive
effects being delayed in onset vs. circulating nitrite/cGMP concentrations
and persisting despite the return of the latter to baseline values. These
observations differ considerably from the short-lived BP-lowering effects
of a single intravenous injection of nitrite, thus supporting the role of a
non-canonical vasodilator effect via a mechanism that is independent of
the NO-cGMP pathway. Our results are consistent with the notion that
nitrite has signalling properties in its own right9 and provides evidence
for the notion that nitrite can act as an indirect oxidant. Our next efforts
focused on how nitrite might induce vasorelaxation and lower blood
pressure. Using a combination of biochemical analytical tools and a ge-
netic KI mouse model, we finally demonstrate that the blood pressure
lowering effects of nitrite are mediated by PKG1a oxidation following
H2O2 and cysteine/glutathione persulfide formation in the resistance vas-
culature. A conceivable explanation for which evidence exists in the
literature is that nitrite acts as an indirect oxidant that mediates oxidation
of other biological targets.
We previously demonstrated that oxidants such as H2O2 can activate
PKG1a independently of the classical NO-sGC-cGMP pathway by form-
ing a disulfide bond at Cys42 to dilate resistance vessels and lower blood
pressure.13 Consistent with this finding, PKG1a-KI mice in which WT ki-
nase has been replaced by a ‘redox-dead’ serine residue (C42S mutant)
cannot transduce oxidant signals because their PKG does not harbour
the redox-sensing thiol, rendering these mice unable to lower blood
pressure via an oxidative mechanism.13 Independent of this, we demon-
strated that nitrite chemically/functionally interacts with H2S
24 and that a
single bolus application of nitrite triggers long-lasting alterations in myo-
cardial redox status with dramatic alterations in the cardiac mitochon-
drial proteome.10 We here sought to integrate these different strands of
information and assessed whether nitrite could produce a metabolic sig-
nature consistent with a process involving thiol/sulfide oxidation and
whether this might be associated with PKG1a dimerization to mediate
vasorelaxation and blood pressure reduction.
Whilst the resistance vessels are the primary determinant of diastolic
and mean blood pressure, most vascular studies investigated the effects
of nitrite in the aorta and have shown NO-dependent effects. Here, we
assessed both the aorta and the mesenteric resistance vessels from WT
and C42S PKG1a KI mice. Unlike the aorta, it was evident in the isolated
resistance vessels from WT mice that nitrite-mediated vasodilatory
effects were NO-sGC independent. Moreover, the mesenteries from
mice expressing the ‘redox-dead’ C42S form of PKG1a were relatively
insensitive in their vasodilatory response to nitrite compared to WT.
Based on these findings, we anticipated that the long-lasting in vivo blood
pressure lowering effect of nitrite would also be diminished in the KI
mice. Indeed, this was found to be the case because nitrite decreased
blood pressure via non-canonical oxidative activation of PKG1a,
whereas the KI mice were resistant to this hypotensive response.
Nitrite has the ability to reduce the rate of H2O2 decomposition by
binding to the haem moiety of catalase thereby inhibiting enzyme
activity23,25; thus we reasoned that nitrite may inhibit catalase activity
and possibly increase H2O2 levels, especially in resistance vessels, and
this may be responsible for the vasoactivity observed. Exploratory stud-
ies on the inhibition of catalase activity by nitrite in mouse liver tissue
Figure 4 In separate group of mice (C57BL/6), mesenteric resistance and thoracic aorta blood vessels were harvested following bolus i.p. administration
of vehicle control or sodium nitrite (1, or 10 mg/kg) in WT mice (C57BL/6) for 1 or 24 h. Hydrogen peroxide (H2O2) levels were measured in (A) mesen-
teric resistance vessels (n= 5–8) and (B) thoracic aorta (n= 7–9). Data are expressed as mean ± S.E.M. *P<_ 0.05 as determined by one-way ANOVA with
Dunnett’s test.
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in vitro confirmed that this may be a viable mechanism. In the vasculature,
H2O2 concentrations were found to remain elevated for prolonged peri-
ods of time in the mesenteric resistance vessels when compared with
conduit vessels. Although these observations would seem to provide a
mechanism that could explain the NO-independent actions of nitrite as
a vasorelaxant, previous studies reporting H2O2-mediated PKG1a acti-
vation required high concentrations of this oxidant,12 suggesting the ef-
fect may not be entirely due to H2O2 directly.
Reactive sulfur-containing species, such as CysSSH have been
known to exist endogenously, but the physiological relevance of these
species remains incompletely understood. CysSSH evidently generates
GSSH, and previous work from our group has shown that these reac-
tive species act as potent scavengers of oxidants such as H2O2, which
contributes to cellular redox signalling.16 Furthermore, Stubbert
et al.14 reported that polysulfur species derived from H2S oxidation
are capable of activating PKG1a via oxidation. Therefore, the genera-
tion of polysulfur species may represent an NO-independent mecha-
nism of PKG1a activation, which could mediate vasorelaxation. Thus,
the ability for nitrite to oxidatively activate PKG1a may be due to addi-
tional generation of polysulfur species. Indeed, there is precedence for
the interaction of nitrite with sulfide in forming another reactive sulfur
species, nitrosopersulfide, in the literature.24 Previous reports indicate
that analysis of CysSSH, GSSH, and HSSH (disulfane) can serve as de-
tectable surrogates for overall levels of cellular polysulfur species,
since they are all in dynamic equilibrium.26,27 Thus, to test the hypothe-
sis that nitrite generates polysulfur species in vivo, the concentrations
of all three compounds were determined by mass spectrometry in
conduit and mesenteric resistance vessels of WT mice 1 and 24 h after
nitrite administration. We observed dose-dependent increases in
CysSSH and GSSH in the resistance vessels with progressively lower
concentrations of HSSH. Since disulfane is highly reactive, it may imme-
diately react as intracellular disulfide concentrations rise to produce
CysSSH and GSSH. In contrast to our findings in resistance vessels, no
increases in CysSSH or GSSH were apparent in conduit vessels. These
observations demonstrate that bolus applications of nitrite trigger pol-
ysulfur species formation through an NO-independent mechanism al-
ready at low-to-moderate pharmacological doses with marked
differences between vascular beds. Interestingly, persulfide formation
from the resistance vessels matched the temporal profile of nitrite
effects on H2O2 and blood pressure.
Thus far, we demonstrated that nitrite is capable of eliciting increases
in H2O2 and polysulfur species, with greater propensity for resistance
vessels than conduit vessels. It is intriguing to speculate that both events
are related and that the source of the polysulfur species is via H2O2-me-
diated oxidation of reduced thiol species. In further in vitro studies, we
thus sought to confirm experimentally that H2O2 is capable of inducing
polysulfidation when inorganic sulfide and cysteine are present. This was
indeed found to be the case under a variety of conditions (pH
Figure 5 Mesenteric resistance and thoracic aorta blood vessels were harvested from WT mice (C57BL/6) treated with bolus i.p. administration of vehi-
cle control or sodium nitrite (0.1, 1, and 10 mg/kg) for 1 or 24 h. The levels of persulfides (CysSSH, GSSH, and HSSH) were analysed by liquid chromatogra-
phy-electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS) following derivation with b-(4-hydroxyphenyl)ethyliodoacetamide (HPE-IAM).
Data are represented as mean ± S.E.M (n= 5–8). *P<_ 0.05 as determined by two-way ANOVA with Tukey’s test (A–F).
58 M. Feelisch et al.
D
ow
nloaded from
 https://academ
ic.oup.com
/cardiovascres/article-abstract/116/1/51/5542837 by U
niversity of East Anglia user on 31 January 2020
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
.
dependence and H2O2 concentrations) and similar results were ob-
served with glutathione/sulfide/H2O2. Taken together, these reactions
strongly suggest that nitrite can indirectly contribute to polysulfide for-
mation by acting as an amplifier of endogenous H2O2 concentrations.
Although it is intriguing to speculate that nitrite may elicit vasorelaxa-
tion via its capacity to raise H2O2 levels which subsequently give rise to
organic persulfides which, in turn, activate PKG1a, it is important to reit-
erate that detection of CysSSH/GSSH is merely indicative of the general
presence of polysulfur species (including protein per- and polysulfides)26
and that these particular species are not necessarily solely responsible
for the biological effects observed herein. What detection of these spe-
cies does indicate, however, is the presence of an oxidizing environment
consistent with the notion of oxidative PKG1a activation. Due to the an-
alytical challenges and rapid interconversion of reactive sulfur species it
is currently not possible to disentangle these reaction channels further.
Nevertheless, the key findings of this work are that nitrite—when ap-
plied i.p.—is capable of creating an oxidizing environment in vivo, as evi-
denced by increases in H2O2 and polysulfide concentrations in vascular
tissue, favouring PKG1a dimerization, and that these effects occur pri-
marily in resistance vessels. While it has been reported that nitrite is ca-
pable of inhibiting catalase (which we confirm to also occur in tissues),
and this is a possible pathway through which nitrite creates an oxidizing
environment, the exact mechanism(s) by which this occurs are not
established. We cannot exclude, for example, that nitrite also increases
vascular NADPH oxidase activity28 and/or up-regulates SOD29 and/or
increases superoxide/H2O2 formation by interfering with electron trans-
fer processes in the mitochondria; these possibilities warrant further in-
vestigation. Furthermore, increases in resistance vessel H2O2
concentration were similar at 1 and 10 mg nitrite, which may explain the
absence of dose-response for blood pressure lowering over the range of
doses explored.
The ability of nitrite to elicit its vasoactive effects to a greater extent in
resistance vs. conduit vessels is intriguing and requires independent con-
firmation. This mechanism is at odds with nitrite’s currently accepted
mode of action (Figure 7) and represents an unusual case of non-
canonical pharmacology whereby a short-lived pro-oxidant elicits long-
Figure 6 Cysteine persulfide (CysSSH) and polysulfides formation during various reactions. (A) pH conditions (5, 6, 7.5, and 9) in the presence of cysteine
(100mM), sulfide (NaHS; 100mM), hydrogen peroxide (H2O2; 100mM) in 50 mM Acetate buffer (pH 5 and 6), or Tris/HCL (pH 7.5 and 9) or HPE-IAM
(2 mM). (B) H2O2 concentrations (0, 0.01, 0.05, 0.1, and 1 mM) in the presence of cysteine (100mM), NaHS (100mM) in 50 mM Tris/HCL pH 7.5. Similar
results were obtained with glutathione/sulfide mixtures, although final concentrations of GSSH achieved were less compared to the corresponding cysteine
analogue. All reactions were also accompanied by the formation of thiosulfate (S2O
2-
3 ) and small concentrations of the corresponding trisulfide (data not
shown). (C) Interaction of cysteine (100mM) or (D) Glutathione (GSH; 100mM) in the presence of NaHS (100mM), H2O2 (100mM) in 50 mM Tris/HCL (pH
7.5). Data presented are from one single independent experiment for each condition.
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lasting hemodynamic effects in vivo. To our knowledge, this is the first re-
port for such a mechanism in resistance vessels in vivo.
These findings may potentially be relevant not only to pharmacologi-
cal, but also to physiological concentrations to nitrite. A previous study
reported that antibacterial mouthwash reduced plasma nitrite and in-
creased blood pressure in treated hypertensive patients.30 Herein, we
demonstrated that the delayed but sustained blood pressure lowering
effect of nitrite was markedly attenuated in the C42S PKG1a KI vs. the
WT mice. Furthermore, we also confirm a previous report that the base-
line blood pressure was higher in the C42S PKG1a KI mice.13 This could
potentially be related to effects of physiological concentrations of nitrite
on PKG oxidation state or may be consistent with a previous report of
impaired acetylcholine mediator effects observed in the C42S PKG1a
KI.13 Mesenteries from KI mice were deficient in their responses to
H2O2 or acetylcholine, as well as the latter in the presence of L-NAME
and indomethacin to remove vasodilation by classical nitric oxide- or
prostacyclin-dependent mechanisms.6 This deficiency in acetylcholine-
dependent relaxation in the C42S PKG1a KI is consistent with the
endothelium-derived hyperpolarizing factor-dependent component of
vasodilation induced by this neurotransmitter being significantly medi-
ated by H2O2 generation.
31 Indeed, evidence was presented that C42S
PKG1a is deficient in activation by cGMP, although whether this muta-
tion impacts the affinity with cGMP was not determined, and this was
suggested to underlie the loss of function observed in C42S PKG1a KI
mice.32 However, the studies comparing the response of isolated resis-
tance vessels of these mutant mice to WT controls, showed their vaso-
dilation to NO donors or a cell-permeable cGMP analogue were the
same.13
Although oxidation of C42 has been implicated in the targeting and
the oxidation of PKG1a, there is additional complexity because of the
potential roles of other redox-active cysteines and the interrelationship
between cGMP-binding and kinase oxidation. It may be that C42 is more
important for targeting the kinase to its substrates, and that cGMP or ox-
idation of another cysteines is required for kinase competency.33 For ex-
ample, nitroxyl donors were shown to induce a disulfide at C42 as well
as an intra-disulfide between C117 and 195 in the high-affinity cGMP-
binding site of PKG1a—with the latter oxidation mediating most of the
activation induced by this nitro-oxidative intervention.34 C195 was also
shown to adduct the electrophile 8-nitro-cGMP, with this S-guanylation
modification leading to persistent activation of the kinase.35
Hyperoxidation of C117 has been implicated as a mechanism of PKG1a
activation by H2O2,
36 whilst activation by this oxidant was not observed
by others.32 In summary, the redox control of PKG1a is complex, with
our understanding continuing to evolve as contemporary studies on the
subject emerge. Nevertheless, a casual role for PKG1a C42 oxidation in
oxidant or endothelium-derived hyperpolarizing factor-dependent vaso-
dilation is supported by a number of studies.
The generation of polysulfur species is dependent on the presence of
cysteine and/or H2S.
17,37 Thus, if PKG1a activation is polysulfide-medi-
ated (as our in vivo experiments suggest) the generation of H2S in the tar-
get tissues becomes an important factor for the action of nitrite and may
contribute to the tissue specificity of the observed effects. The overall
outcome of these reactions on the effective concentrations of CysSSH
and related species (and thus the net effect on physiological function)
appears to be complex and tissue/organ-specific, as illustrated by the dif-
ferences in regulation between resistance and conduit vessels in the pre-
sent study. The factors contributing to these differences (e.g. oxygen
tension, oxidative stress) warrant further investigation.
In summary, this study reports a novel finding, whereby under physio-
logical conditions nitrite induces long-lasting blood pressure lowering
effects independent of NO-induced cGMP elevations. We show that ni-
trite lowers blood pressure by mediating oxidation of PKG1a. This
mechanism has been shown by using ‘redox-dead’ C42S PKG1a KI mice,
which cannot activate oxidant signals. We observed dose-dependent
vasorelaxant responses to nitrite in the PKG1a WT isolated resistance
vessels, but the vasodilatory response to nitrite were blunted in the
C42S PKG1a KI mice. These findings were further substantiated by mon-
itoring blood pressure in vivo, since nitrite was unable to lower blood
pressure in the redox-dead C42S PKG1a KI mice compared with WT
littermates. We also identified that the effect of nitrite was mediated via
the generation of H2O2, with consecutive production of persulfide spe-
cies (CysSSH and GSSH) in the resistance vessels, which oxidatively acti-
vate PKG1a. Our study concludes that a single bolus application of
nitrite has the ability to act as a redox regulator during physiological con-
ditions to induce long-lasting blood pressure lowering effects, providing
a new prospect for therapeutic strategy in treating the global healthcare
burden of hypertension. Future investigations are warranted to address
the significance of this redox pathway in hypertensive and other cardio-
vascular disease models. Furthermore, our findings raise the possibility of
identifying other molecules capable of modulating this novel pathway
that may have therapeutic potential as hypertensive agents.
Figure 7 Proposed mechanism of action involved in nitrite-mediated
vasorelaxation, including the canonical nitrite reduction pathway (left—
blue panel) and the novel nitrite oxidation pathway (right—red panel).
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Translational perspective
Despite current pharmacotherapies and interventional procedures, arterial hypertension remains a global health burden. Thus, novel therapeutic
interventions are urgently required. Nitrite exerts vasorelaxant effects of potential therapeutic relevance under normal physiological conditions, yet
the mechanism of action remain unknown. Here, we present evidence that in normoxia nitrite lowers blood pressure via a novel redox mechanism.
This occurs independent of nitric oxide by generating hydrogen peroxide and persulfide, which subsequently activates PKG1a by oxidation.
Targeting this novel pathway may provide new prospects for anti-hypertensive therapy and other cardiovascular-related diseases.
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